ES2170956T3 - Derivados 2-alquenilicos de acido ciclopentan(en)oico como agentes terapeuticos en el tratamiento de hipertension ocular. - Google Patents

Derivados 2-alquenilicos de acido ciclopentan(en)oico como agentes terapeuticos en el tratamiento de hipertension ocular.

Info

Publication number
ES2170956T3
ES2170956T3 ES97925558T ES97925558T ES2170956T3 ES 2170956 T3 ES2170956 T3 ES 2170956T3 ES 97925558 T ES97925558 T ES 97925558T ES 97925558 T ES97925558 T ES 97925558T ES 2170956 T3 ES2170956 T3 ES 2170956T3
Authority
ES
Spain
Prior art keywords
link
condition
oico
cyclopentan
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97925558T
Other languages
English (en)
Inventor
Michael E Garst
Michael B Roof
Ming F Chan
David F Woodward
Robert M Burk
Todd S Gac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Sales LLC
Original Assignee
Allergan Sales LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Sales LLC filed Critical Allergan Sales LLC
Application granted granted Critical
Publication of ES2170956T3 publication Critical patent/ES2170956T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE AL USO DE PROSTAGLANDINAS MODIFICADAS POR UNA CADENA OMEGA COMO HIPOTENSIVOS OCULARES. LOS DERIVADOS UTILIZADOS SEGUN LA INVENCION QUEDAN REPRESENTADOS POR LA FORMULA ESTRUCTURAL (I): EN LA QUE LOS SEGMENTOS DE RAYADO SENCILLO REPRESENTAN ENLACES AL ; LOS SEGMENTOS ONDULADOS REPRESENTAN UN ENLACE AL O BE ; LAS LINEAS DE RAYAS REPRESENTAN UN ENLACE DOBLE O UN ENLACE SENCILLO; X SE SELECCIONA DEL GRUPO QUE CONSISTE EN - OR Y N(R 2 ); Y ES = O O REPRESENTA 2 RADICALES HIDROGENO, CON LA CONDICION DE QUE Y REPRESENTE 2 RADICALES HIDROGENO CUANDO X SEA OH; R ES HIDROGENO O UN RADICAL INFERIOR QUE TIENE HASTA SEIS ATOMOS DE CARBONO; R ES = O O HIDROXI; M ES = 0, 2, 4 O 6 CON LA CONDICION DE QUE M NO SEA 4 CUANDO EL SEGMENTO ONDULADO REPRESENTE UN ENLACE BE ; N ES 0, 2, 4 O 6, X E Y SON 0 O 1, CON LA CONDICION DE QUE X SEA 1 CUANDO Y ES 0 E Y SEA 1 CUANDO X ES 0; O DERIVADOS 9, 11 Y/O 12 DEL ESTER DE DICHOS COMPUESTOS DE FORMULA (I), EJ. UN DERIVADO DEL ESTER DE ALQUILO C 1Y C 6 ; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS.
ES97925558T 1996-05-28 1997-05-14 Derivados 2-alquenilicos de acido ciclopentan(en)oico como agentes terapeuticos en el tratamiento de hipertension ocular. Expired - Lifetime ES2170956T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1843596P 1996-05-28 1996-05-28

Publications (1)

Publication Number Publication Date
ES2170956T3 true ES2170956T3 (es) 2002-08-16

Family

ID=21787915

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97925558T Expired - Lifetime ES2170956T3 (es) 1996-05-28 1997-05-14 Derivados 2-alquenilicos de acido ciclopentan(en)oico como agentes terapeuticos en el tratamiento de hipertension ocular.

Country Status (8)

Country Link
US (1) US6258844B1 (es)
EP (1) EP0912507B1 (es)
JP (1) JP2000511530A (es)
AU (1) AU729318B2 (es)
CA (1) CA2256404A1 (es)
DE (1) DE69710333T2 (es)
ES (1) ES2170956T3 (es)
WO (1) WO1997045405A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0126075D0 (en) * 2001-10-31 2001-12-19 Cascade Biochem Ltd Improvements relating to prostaglandins and their analogues
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US20110124736A1 (en) 2009-11-09 2011-05-26 Allergan, Inc. Compositions and methods for stimulating hair growth
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
CN102757459B (zh) * 2011-04-29 2016-01-27 上海源力生物技术有限公司 用于合成前列腺素类药物的中间体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA88963B (en) * 1987-02-27 1989-11-29 Allergan Inc Prostaglandins useful for lowering intraocular pressure
CA2020254A1 (en) * 1989-07-27 1991-01-28 Ming F. Chan Intraocular pressure reducing 9, 15-diacyl prostaglandins
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
CA2021316C (en) * 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5238961A (en) 1990-06-14 1993-08-24 Allergan, Inc. Pgf 1-alcohols and their use as ocular hypotensives

Also Published As

Publication number Publication date
EP0912507B1 (en) 2002-02-06
CA2256404A1 (en) 1997-12-04
AU729318B2 (en) 2001-02-01
EP0912507A1 (en) 1999-05-06
DE69710333D1 (de) 2002-03-21
JP2000511530A (ja) 2000-09-05
WO1997045405A1 (en) 1997-12-04
DE69710333T2 (de) 2002-09-19
US6258844B1 (en) 2001-07-10
AU3066297A (en) 1998-01-05

Similar Documents

Publication Publication Date Title
ES2131913T3 (es) Derivados de camptotecina.
AR003220A1 (es) Derivados acilados de melatonina; composicion farmaceutica y cosmetica y el uso de los mismos para la preparacion de un medicamento.
ES2059207T3 (es) Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen.
ES2152444T3 (es) Derivados de acido benzazepin-, benzoxazepin- y benzotiazepin-n-acetico, asi como procedimiento para su preparacion y medicamentos que contienen a estos compuestos.
ES2170956T3 (es) Derivados 2-alquenilicos de acido ciclopentan(en)oico como agentes terapeuticos en el tratamiento de hipertension ocular.
ES2089056T3 (es) Derivados de hidrazincarboxamida, un procedimiento para la produccion de los mismos, y usos de los mismos.
ES2161290T3 (es) Derivados de quinazolina.
ES2118283T3 (es) Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos.
ECSP941122A (es) Derivados de 5-arilindoles
ES2124062T3 (es) Derivados de nucleosido fosforotioato, sintesis y uso de los mismos.
AR026593A1 (es) Formulaciones para agentes farmaceuticos ionizables como acidos libres o bases libres
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
ES2181803T3 (es) Acidos 4-biarilbutiricos o 5-biarilpentanoicos sustituidos y sus derivados como inhibidores de las metaloproteasas de matriz.
ES2159734T3 (es) Derivados 2-heteroarilalquenilicos del acido ciclopentano-heptan(en)oico como agentes terapeuticos para el tratamiento de la hipertension ocular.
ES2137182T3 (es) Derivados recombinantes del factor viii humano.
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
ES2163407T3 (es) Derivados piperidinilos tiaciclicos.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
ES2153491T3 (es) Derivados de quinazolina.
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
ES2123873T3 (es) Pirrolocarbazol.
ES2159345T3 (es) Indazolcarboxamidas.
ES2121597T3 (es) Derivados de bencenosulfonamida para el tratamiento de la inestabilidad de la vejiga.
ES2187565T3 (es) Alcaloides indolicos utiles como agentes antiinflamatorios.
ES2143181T3 (es) Derivados biciclicos de isotiourea utiles en terapia.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 912507

Country of ref document: ES